COVID-19 vaccine: AIIMS Delhi to begin recruitment for clinical trials for 6-12 age group from Tuesday
The All India Institute Of Medical Sciences (AIIMS) Delhi will begin recruiting for clinical trials for the 6-12 age group on Tuesday in order to examine the efficacy of COVID-19 vaccines on youngsters (June 15, 2021).
The trial for Bharat Biotech's Covaxin will begin on Tuesday as well. The clinical trials will look at the safety, reactogenicity, and immunogenicity of Covaxin vaccinations in children aged 2 to 18.
The recruiting and clinical study for a single dose of Covaxin for the 12-18 age range has also been completed, according to AIIMS Delhi.